Trial Profile
A study investigating the effect of fingolimod on B-cell populations in multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 18 Nov 2015 New trial record